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Lanthanide-doped nanophosphors have received signifi cant attention for use in biological sensing and imaging due to their unique optical properties. Much like semiconductor quantum dots (QDs), these luminescent nanocrystals offer several advantages over conventional organic fl uorophores, including high photochemical stability, large Stokes shift, and tunable fl uorescence emission. [ 1 ] Up-conversion nanophosphors, which are capable of absorbing two or more low-energy photons to emit a higher-energy photon, also exhibit favorable characteristics such as long fl uorescence lifetimes, no photoblinking, and reduced autofl uorescence. [ 2 ] The recent development of lanthanide-doped nanophosphors that function in the near-infrared (NIR) spectral range optimal for optical transmission through biological tissues (650-900 nm) has attracted great interest towards in vivo bioimaging probes. [3] [4] [5] Alternatively, high-energy radiation, currently employed in medical imaging modalities, such as X-ray computed tomography (CT) or positron emission tomo graphy (PET), may also be used to excite NIR-emitting radioluminescent nanophosphors (RLNPs) for bioimaging.
Recently, RLNPs have been proposed as molecular imaging probes in the development of combined X-ray/optical imaging modalities, such as X-ray luminescence computed tomography (XLCT). [6] [7] [8] This innovative imaging technique provides deep tissue penetration, circumvents tissue autofl uorescence, and simplifi es imaging through optical reconstruction from planar images. Tissue-specifi c accumulation of these RLNPs through molecular targeting strategies [ 9 , 10 ] would allow for localization of lesions, such as tumors, through detection of luminescence induced by narrowly collimated X-rays. In addition, RLNPs capable of activation by radioisotopes, such as PET tracers and radiopharmaceuticals, may enable planar optical detection of radiotherapy or co-localization of molecular targets. To enable these novel imaging modalities, we present a facile procedure to synthesize poly(ethylene glycol) (PEG)-coated RLNPs and examine their ability to serve as optical probes excited by X-rays or radioisotopes.
Conventional X-ray phosphor synthesis processes (e.g., solid state or molten fl ux reactions) are limited in their ability to produce colloidal and monodispersed nanocystals for biological applications. In this work, we utilize a solution-based thermal degradation of organometallic precursors to produce europiumdoped barium yttrium fl uoride nanophosphors with a uniform morphology and narrow size distribution ( Figure 1 A) . Adapted from an up-conversion nanophosphor synthesis route reported by Capobianco et al., [ 11 ] this procedure employs a wellestablished octadecene/oleic acid reaction medium to control nucleation and growth of the crystals. [ 12 , 13 ] Here a europium trifl uoracetate (TFA) precursor was used to incorporate trivalent europium (Eu 3 + ) as a luminescence activator. Oleic acid-capped RLNP produced by this procedure (Figure 1 B) are hydrophobic 4f orbitals. [ 15 ] This unique photophysical feature enables RLNP emission tuning and potentially multiplex imaging by varying dopants in the nanophosphor. Luminescence of the RLNP excited by β + -decay of 18 The RLNPs were visualized by transmission electron microscopy (TEM). Figure 2 A displays the size and cubic morphology of the nanocrystals. Although clustering of the RLNP was observed on the TEM grid as a drying artifact, discrete particles were readily visible due to the high image contrast from the barium (high-Z value) component. Particle-size analysis of the TEM micrograph shows a narrow distribution of RLNP with a mean of ≈ 14 nm (Figure 2 B) . Crystal structure and composition of the RLNP were evaluated by powder X-ray diffraction (XRD) identifying the host as cubic Ba 0.55 Y 0.3 F 2 (ICDD Powder Diffraction File #04-005-9812, Supporting Information, Figure  S1 ). In comparison to co-doped barium yttrium fl uoride nanophosphors produced by the same process, these host crystals differ in morphology (cubic versus tetragonal) and stoichiometry (Ba 0.55 Y 0.3 F 2 versus BaYF 5 ) due to the nature and concentration of the dopants, a phenomenon described recently in the literature. [ 14 ] Quantitative analysis of the RLNP atom ratios obtained by X-ray photoelectron spectroscopy (XPS) corresponds well to the host composition determined by XRD with proportions of Ba, Y, and F in a survey scan equivalent to Ba 0.55 Y 0.3 F 2 (Supporting Information, Figure S2A ). Successful surface modifi cation with PEG was also confi rmed in high-resolution C1s XPS spectra from oleic acid and PEG-coated RLNP shown by a change of shape and shift of the C1s peak (Supporting Information, Figure  S2B and S2C). In addition to enabling dispersion in aqueous solutions, the amphiphilic PEG was chosen for its ability to improve the serum half-life and overall in vivo biocompatibility of the nanophosphor. Free terminal -COOH groups on endgrafted bifunctional PEG chains also provide functionality for conjugation of targeting agents, such as mAbs or peptides, to the RLNPs.
To characterize the optical properties of the RLNPs, their emission spectrum was collected with a CCD coupled spectrograph while the sample was irradiated with X-rays (50 kVp, Figure 2C ). Here the barium component of the RLNPs serves as an effective X-ray absorber with a K-edge at 37.4 keV, which lies within the diagnostic X-ray range. Energy transfer from the host lattice to luminescent centers was observed in characteristic Eu 3 + emission peaks at 597 and 615 nm due to the 5 D 0 → 7 F 1 (magnetic-dipole) and 5 D 0 → 7 F 2 (electronic-dipole) transitions, respectively. In addition, a signifi cant peak at 692 nm resulting from 5 D 0 → 7 F 4 transitions within the so-called "biological window" was also observed. In this NIR spectral region, hemoglobin and water/lipids have their lowest absorption coeffi cient allowing for imaging deeper in tissue. [ 15 , 16 ] The emission peaks of the RLNPs result from the electron confi guration of the Eu 3 + dopant, which serve as trap states within the band gap. [ 17 ] In lanthanide dopants, optical transitions within the 4f orbitals are shielded from interaction with the chemical environment by the 5s and 5p shells, which are lower in energy but spatially located outside of the decreased total light output compared to the FDG control suggesting that the UV-emission by Cerenkov radiation was attenuated by various absorption and energy transfer phenomena. However, samples containing the highest concentration of RLNP (10 mg mL − 1 ) displayed increased radioluminescence intensities suggesting stimulation of photons by higher-energy particles or photons in addition to potential UV excitation. These results suggest that further investigation of the photophysical mechanisms of these nanomaterials is warranted.
To demonstrate the application of RLNPs under biological conditions, pseudo tumors where formed by subcutaneous injection of matrigel containing FDG (left) or FDG w/RLNPs (right). PET imaging was performed to visualize the presence of FDG in the inclusions ( Figure 4 A) . Equal quantities of the radioisotope ( ≈ 55 μ Ci) in each pseudo tumor were verifi ed by summing the total activity over each inclusion in the PET image and by comparing the optical signal in the Cerenkov luminescence image (Supporting Information, Figure S5 ). FDG-stimulated optical imaging of the mice bearing inclusions clearly displayed enhanced emission at 700 nm on the fl ank containing RLNPs (Figure 4 B) . A low-intensity signal was also detected from the FDG inclusion due to the Cerenkov luminescence. To evaluate Figure S3 ). In addition, the characteristic Eu 3 + emission spectrum of the RLNPs stimulated by FDG was verifi ed through serial imaging with 500-800 nm emission fi lters (Supporting Information, Figure S4 ). A plot of the RLNP optical emission at 700 nm illustrates a near-linear increase in luminescence with radioactivity for all samples measured ( Figure 3 A) . RLNP samples containing ≥ 1 mg mL − 1 displayed luminescence intensity above that of the FDG control. Light emitted purely from FDG is attributed to Cerenkov radiation, a phenomenon in which a charged particle passes through a dielectric medium at a speed greater than the speed of light in that medium resulting in the emission of light. [ 18 , 19 ] Although an optical signal from the lowest concentration sample (0.1 mg mL − 1 ) was not signifi cantly detectable above the Cerenkov radiation background (a continuous spectrum with peak emission in the UV), further investigation of optimal dopant concentrations and modifi cation of the RLNP to prevent surface quenching of luminescent centers (i.e., formation of a core-shell structure) is likely to vastly improve radioluminescence efficiency. Rapidly growing interest in Cerenkovbased optical imaging using PET tracers has recently inspired the use of QDs to red-shift Cerenkov luminescence toward tissue penetrating NIR. [20] [21] [22] [23] [24] Here RLNP may function in a similar manner and benefi t from both direct UV excitation of the Eu 3 + luminescent center and scintillation from the cascade of energetic electrons induced by positron interactions within the host. To briefl y investigate the optical properties of the RLNP, radioluminescence measurements acquired with FDG and under open fi lter conditions were analyzed (Figure 3 B) . Interestingly, samples containing lower concentrations RLNP (0.1 and 1.0 mg mL − 1 ) with 33 μ Ci FDG displayed temperature. The resulting colloidal mixture was combined with EtOH (200 mL) to precipitate the oleic acid-capped RLNPs. The fl occulated RLNPs were isolated by decanting the solvent and further purifi ed by redispersing the nanophosphors in toluene (10 mL) followed by precipitation and decanting with EtOH for two additional cycles of washing. The isolated oleic acid coated RLNPs were then dispersed in DCM (200 mL) for surface modifi cation with diacid PEG (2 mL) under ultrasonic agitation (Branson Ultrasonic Corp., Danbury, CA) at 40 ° C for 1 h. The resulting PEGylated RLNPs were isolated by evaporating the DCM and purifi ed by three rounds of dispersion/centrifugation with D.I. water.
Nanophosphor Characterization : Transmission electron microscopy (TEM) samples were prepared by dipping 400 mesh copper grids (Veco, Ted Pella, Redding, CA) in a diluted suspension of RLNPs in toluene. The grids were then dried and imaged on a JEOL TEM1230 (Tokyo, Japan) operating at 80 KV. TEM images were acquired with a Gatan 967 (Pleasanton, CA) slow scan, cooled CCD camera. NIH ImageJ with the particle size analyzer (PSA) macro was used to calculate the particle size distribution. Powder X-ray diffraction (XRD) patterns were acquired from dried samples placed on a silicon holder with a PANalytical X'Pert (Almelo, Netherlands) diffractometer using Cu-K α radiation ( λ = 1.541 Å) at 40 kV and 20 mA. X-ray photoelectron spectroscopy (XPS) analysis were carried out using a Surface Science Instrument S-probe spectrophotometer (Newburyport, MA) with a monochromatized Al X-ray source and 5 eV fl ood gun for charge neutralization. XPS samples were prepared by drying a fi lm of RLNPs on an aluminum sheet. X-ray spot size for the acquisition was approximately 800 μ m. Pressure in the analytical chamber during spectral acquisition was less than 5 × 10 − 9 Torr.
X-ray Radioluminescence Characterization and Imaging : To acquire the radioluminescence emission spectrum of the RLNP, a pelletized sample irradiated with X-ray source (50 kVp, Nucletron, Oldelft, Netherlands) was collected with a CCD coupled spectrograph (Princeton Instruments, Trenton NJ). X-ray radioluminescence imaging was performed on biological samples at 37 ° C using a custom system described previously. [ 6 ] FDG Radioluminescence Characterization and Imaging : Luminescence stimulated by positron emission was examined by mixing various concentrations of RLNPs with FDG in wells of a 96-well plate. The samples containing the described quantities of RLNPs (0, 0.1, 1.0, 5.0, and 10 mg mL − 1 ) and FDG (3.0, 16, and 33 μ Ci at the start of the measurements) were 200 μ L in volume. Imaging was performed using a conventional small-animal optical imaging system (IVIS Spectrum, Caliper, Hopkinton, MA). Image analysis was conducted using MATLAB. Optical fi lter transmission, radioactive decay, and fl at-fi eld corrections were applied to the images. Photon count (average and standard deviation) was measured within circular regions-of-interests centered on each well.
In Vivo Radioluminescence Imaging : All animal studies were performed in accordance to IACUC guidelines. Nude mice ( n = 3) were subcutaneously injected with a mixture of matrigel and FDG (left fl ank) and a mixture of matrigel, FDG, and 20 mg RLNP (right fl ank). MicroPET imaging of the mice was performed on a small-animal PET R4 rodent model scanner (Siemens Medical Solutions USA, Inc., Knoxville, TN). Optical imaging of FDG-stimulated radioluminescence was performed using a conventional small-animal optical imaging system (IVIS Spectrum).
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X-ray radioluminescence of the biological samples, the mice were sacrifi ced and frozen for > 1 week to allow for complete decay of the 18 F (half-life 2 hours) and warmed to 37 ° C prior to imaging in a custom X-ray optical imaging system, described previously. [ 6 ] Luminescence generated by RLNPs was observed from the corresponding inclusion upon X-ray excitation (Figure 4 C) . No detectable signal was observed in the decayed FDG inclusion. The preceding results demonstrate the feasibility of applying RLNPs to enable radioluminescence detetection in these novel imaging modalities.
In summary, we have presented a facile synthesis and surface modifi cation process to produce water-soluble radioluminescent cubic Ba 0.55 Y 0.3 F 2 :Eu 3 + nanophosphors. Physiochemical and luminescence characterization of the RLNPs confi rm their structure, size, morphology, and optical properties critical to their ability to function as radioluminescent bioimaging probes. Although bulk phosphors and scintillators have been well studied for various technological applications, the unique properties of colloidal nanophosphors warrant further investigation into their photophysical mechanisms. As bioimaging probes, RLNPs offer several advantages over pure optical-based imaging agents, including greater tissue penetration, elimination of autofl uoresence, simplifi ed tomographic image reconstruction, and inherent multimodality with conventional radiological imaging techniques. Disadvantages of in vivo RLNP imaging are the use of ionizing radiation and the unknown long-term toxicity and clearance of these nanomaterials, although such limitations do not preclude their near-term use as tools in preclinical small animal imaging studies. As proofof-principle demonstration, PEGylated RLNPs under biological conditions were shown to emit luminescence under excitation by either 18 F radioisotope or X-rays. This capability provides the potential to enable novel imaging modalities, such as XLCT or deep tissue Cerenkov luminescence imaging.
Experimental Section
Materials : Barium acetylacetonate hydrate, oleic acid, 1-octadecene, poly(ethylene glycol) diacid (MW 600), and dichloromethane (DCM) were purchased from Sigma-Aldrich (St. Louis, MO). Trifl uoroacetic acid (CF 3 COOH) and 200 proof ethanol (EtOH) were purchased from Fisher Chemical (Fairlawn, NJ). Europium oxide (Eu 2 O 3 ), yttrium oxide (Y 2 O 3 ) and toluene were purchased from Acros Organics (Morris Plains, NJ). All reagents were used without further purifi cation. Deionized (D.I.) water was obtained from an ultrapure water purifi cation system (Barnstead Nanopure, Thermo Scientifi c, Dubuque, IA). Matrigel was purchased from BD Biosciences (San Diego, CA).
Nanophosphor Synthesis : Eu 3 + -doped barium yttrium fl uoride radioluminescent nanophosphors (RLNPs) were synthesized by a thermodegradation of organometallic precursors in the presence of oleic acid and 1-octadecene. [ 11 -13 ] Briefl y, europium and yttrium trifl uoroacetates were obtained through dissolution of corresponding oxides (16.2 mg Eu 2 O 3 and 208 mg Y 2 O 3 ) in trifl uoroacetic acid over 48 h at 27 ° C. [ 25 ] The resulting trifl uoroacetate products were isolated by distillation and combined with barium acetylacetonate (1.0 g). The mixture of organometallic precursors was then dissolved in octadecene/ oleic acid (40 mL, 1:1 v/v). The solution was sonicated for 15 min to ensure dissolution of the solid reagents and facilitate degassing of the solvent. The homogenized solution was then heated to 120 ° C and stirred under vacuum for 15 min, heated further to 300 ° C under argon atmosphere for 1 h, and subsequently allowed to cool to room
